Literature DB >> 20830797

Autistic and psychiatric findings associated with the 3q29 microdeletion syndrome: case report and review.

Fabiola Quintero-Rivera1, Pantea Sharifi-Hannauer, Julian A Martinez-Agosto.   

Abstract

The screening of individuals with mild dysmorphic features and mental retardation using whole genome scanning technologies has resulted in the delineation of several previously unrecognized microdeletion syndromes. Microdeletion of 3q29 has been recently described as one such new syndrome. The clinical phenotype is variable despite an almost identical submicroscopic deletion size in most cases. We report on two individuals that further expand the clinical presentation of this rare disorder and compare the findings with earlier reports to refine the 3q29 microdeletion syndrome phenotype. The propositi are a 10-year-old female and a 15-year-old male, who have in common intellectual disabilities, a history of autism and psychiatric symptoms ranging from bipolar disorder presenting with increasing suicidal ideation to aggressive behavior and general anxiety. Other shared physical findings include asymmetric face, high-nasal bridge, crowded/dysplastic teeth, and tapered fingers. Oligonucleotide array-based chromosomal microarray analysis (CMA) using a genome-wide SNP array identified a de novo subtelomeric microdeletion of chromosome region 3q29 ranging from 1.6 to 2.1 Mb. The region of overlap encompasses 20 RefSeq genes, including FBX045, DLG1, and PAK2. These genes are related to neuronal postsynaptic membrane function and PTEN signaling, suggesting a role for synaptic connectivity dysfunction in the etiology of autism in these children. The novel clinical presentation of our patients expands the clinical spectrum of the 3q29 microdeletion syndrome and provides additional insights into the pathophysiology of autism and psychiatric disorders.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20830797     DOI: 10.1002/ajmg.a.33573

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  38 in total

Review 1.  Unraveling the genetic architecture of copy number variants associated with schizophrenia and other neuropsychiatric disorders.

Authors:  Timothy P Rutkowski; Jason P Schroeder; Georgette M Gafford; Stephen T Warren; David Weinshenker; Tamara Caspary; Jennifer G Mulle
Journal:  J Neurosci Res       Date:  2016-11-08       Impact factor: 4.164

2.  Genetic variability in scaffolding proteins and risk for schizophrenia and autism-spectrum disorders: a systematic review.

Authors:  Jordi Soler; Lourdes Fañanás; Mara Parellada; Marie-Odile Krebs; Guy A Rouleau; Mar Fatjó-Vilas
Journal:  J Psychiatry Neurosci       Date:  2018-05-28       Impact factor: 6.186

3.  Prospective diagnostic analysis of copy number variants using SNP microarrays in individuals with autism spectrum disorders.

Authors:  Caroline Nava; Boris Keren; Cyril Mignot; Agnès Rastetter; Sandra Chantot-Bastaraud; Anne Faudet; Eric Fonteneau; Claire Amiet; Claudine Laurent; Aurélia Jacquette; Sandra Whalen; Alexandra Afenjar; Didier Périsse; Diane Doummar; Nathalie Dorison; Marion Leboyer; Jean-Pierre Siffroi; David Cohen; Alexis Brice; Delphine Héron; Christel Depienne
Journal:  Eur J Hum Genet       Date:  2013-05-01       Impact factor: 4.246

4.  Copy number variants for schizophrenia and related psychotic disorders in Oceanic Palau: risk and transmission in extended pedigrees.

Authors:  Nadine Melhem; Frank Middleton; Kathryn McFadden; Lambertus Klei; Stephen V Faraone; Sophia Vinogradov; Josepha Tiobech; Victor Yano; Stevenson Kuartei; Kathryn Roeder; William Byerley; Bernie Devlin; Marina Myles-Worsley
Journal:  Biol Psychiatry       Date:  2011-10-07       Impact factor: 13.382

5.  Genetic variability in scaffolding proteins and risk for schizophrenia and autism-spectrum disorders: a systematic review.

Authors:  Jordi Soler; Lourdes Fañanás; Mara Parellada; Marie-Odile Krebs; Guy A Rouleau; Mar Fatjó-Vilas
Journal:  J Psychiatry Neurosci       Date:  2018-07       Impact factor: 6.186

6.  The 3q29 microdeletion syndrome: report of three new unrelated patients and in silico "RNA binding" analysis of the 3q29 region.

Authors:  Majed J Dasouki; Gerald H Lushington; Karine Hovanes; James Casey; Mereceds Gorre
Journal:  Am J Med Genet A       Date:  2011-05-27       Impact factor: 2.802

7.  NCBP2 modulates neurodevelopmental defects of the 3q29 deletion in Drosophila and Xenopus laevis models.

Authors:  Mayanglambam Dhruba Singh; Matthew Jensen; Micaela Lasser; Emily Huber; Tanzeen Yusuff; Lucilla Pizzo; Brian Lifschutz; Inshya Desai; Alexis Kubina; Sneha Yennawar; Sydney Kim; Janani Iyer; Diego E Rincon-Limas; Laura Anne Lowery; Santhosh Girirajan
Journal:  PLoS Genet       Date:  2020-02-13       Impact factor: 5.917

8.  High frequencies of de novo CNVs in bipolar disorder and schizophrenia.

Authors:  Dheeraj Malhotra; Shane McCarthy; Jacob J Michaelson; Vladimir Vacic; Katherine E Burdick; Seungtai Yoon; Sven Cichon; Aiden Corvin; Sydney Gary; Elliot S Gershon; Michael Gill; Maria Karayiorgou; John R Kelsoe; Olga Krastoshevsky; Verena Krause; Ellen Leibenluft; Deborah L Levy; Vladimir Makarov; Abhishek Bhandari; Anil K Malhotra; Francis J McMahon; Markus M Nöthen; James B Potash; Marcella Rietschel; Thomas G Schulze; Jonathan Sebat
Journal:  Neuron       Date:  2011-12-22       Impact factor: 17.173

Review 9.  A clinical case report and literature review of the 3q29 microdeletion syndrome.

Authors:  Devin M Cox; Merlin G Butler
Journal:  Clin Dysmorphol       Date:  2015-07       Impact factor: 0.816

10.  Co-occurrence of autism, childhood psychosis, and intellectual disability associated with a de novo 3q29 microdeletion.

Authors:  Angela Sagar; Jeffrey R Bishop; D Clare Tessman; Steve Guter; Christa L Martin; Edwin H Cook
Journal:  Am J Med Genet A       Date:  2013-02-26       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.